4.55
price up icon2.02%   0.09
after-market Handel nachbörslich: 4.46 -0.09 -1.98%
loading

Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten

pulisher
09:53 AM

BioAge Labs announces first participant dosed in Phase 1 trial of BGE-102 - TipRanks

09:53 AM
pulisher
09:17 AM

BioAge Labs begins phase 1 trial of oral NLRP3 inhibitor for obesity - Investing.com Australia

09:17 AM
pulisher
09:01 AM

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor - MarketScreener

09:01 AM
pulisher
09:00 AM

25% Weight Loss: BioAge's New Oral Drug Shows Breakthrough Results Combined with GLP-1s in Pre-Clinical Study - Stock Titan

09:00 AM
pulisher
Aug 14, 2025

Can BioAge Labs Inc. Regain Lost Ground This Quarter2025 Bull vs Bear & Free Fast Entry Momentum Trade Alerts - newsyoung.net

Aug 14, 2025
pulisher
Aug 12, 2025

What is BioAge Labs Inc. s revenue forecast3x Potential Swing Trade Ideas - newsyoung.net

Aug 12, 2025
pulisher
Aug 12, 2025

BioAge Labs Reports Q2 2025 Financial Results and Progress - TipRanks

Aug 12, 2025
pulisher
Aug 11, 2025

Q3 EPS Estimates for BioAge Labs Decreased by William Blair - MarketBeat

Aug 11, 2025
pulisher
Aug 09, 2025

Smart tools for monitoring BioAge Labs Inc.’s price actionAI-Powered Stock Trend Movement Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

What makes BioAge Labs Inc. stock price move sharplyFree Growth Focused Entry Plan Suggestions - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Cautious Outlook on BioAge Labs, Inc. Amid Uncertainties in Clinical Developments and Market Perception - TipRanks

Aug 08, 2025
pulisher
Aug 06, 2025

BioAge Labs (BIOA) Q2 Revenue Hits $2.4M - The Motley Fool

Aug 06, 2025
pulisher
Aug 06, 2025

BioAge Labs (BIOA) Q2 Revenue Hits $2.4M - Nasdaq

Aug 06, 2025
pulisher
Aug 06, 2025

BioAge Labs, Inc. Advances Clinical Pipeline with BGE-102 Phase 1 Trial Set for 2H 2025 and Expands APJ Agonist Pipeline - Quiver Quantitative

Aug 06, 2025
pulisher
Aug 06, 2025

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Manila Times

Aug 06, 2025
pulisher
Aug 06, 2025

BioAge Labs Q2 2025: BGE-102 on track for Phase 1, expanded APJ pipeline, strengthened discovery platform. - AInvest

Aug 06, 2025
pulisher
Aug 05, 2025

Full technical analysis of BioAge Labs Inc. stockFree Fundamental Growth Stock Analysis - Newser

Aug 05, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about BioAge Labs Inc.Maximize your returns with expert insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive BioAge Labs Inc. stock higher in 2025Dynamic investment growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is BioAge Labs Inc. company’s growth strategyHigh-margin investment plays - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BioAge Labs Inc. compare to its industry peersDiscover undervalued stocks before they soar - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is BioAge Labs Inc. a growth stock or a value stockSkyrocketing returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell BioAge Labs Inc. stock in 2025Rapid market gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for BioAge Labs Inc.Navigate the market with precision tools - Jammu Links News

Aug 02, 2025
pulisher
Jul 31, 2025

BioAge Labs Requests to Dismiss Class Action Filed by Investors - TradingView

Jul 31, 2025
pulisher
Jul 31, 2025

BioArctic's Leqembi Achieves Massive 23.1B Yen Quarter: China Stockpiling Drives 280% Royalty Jump - Stock Titan

Jul 31, 2025
pulisher
Jul 30, 2025

BioAge (BIOA) to Analyze Over 17,000 Biobank Samples for Drug Discovery - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-29 06:11:56 - beatles.ru

Jul 30, 2025
pulisher
Jul 29, 2025

Price Channel Expanding on BioAge Labs Inc.’s ChartAccurate Buy Point for Momentum Stocks Detected - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

BioAge to Analyze Over 17,000 Biobank Samples for Drug Discovery - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

How to interpret RSI for BioAge Labs Inc. stockFree Trade Ready Stock Watch for Short Term - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 09:16:13 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Can BioAge Labs Inc. Bounce Back From Weekly LowWeekly Top Gainers Forecast Watchlist Released - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Will BioAge Labs Inc. Benefit From Sector TailwindsReal Time Stock Movement Analysis Indicates Breakout - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Competitive Positioning of BioAge Labs Inc.: Is It Leading or LaggingLow Risk Entry Points - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is BioAge Labs Inc. company’s balance sheetInvest confidently with data-backed picks - Jammu Links News

Jul 28, 2025
$29.05
price up icon 2.80%
$17.96
price down icon 0.22%
drug_manufacturers_specialty_generic RDY
$14.22
price up icon 0.78%
$10.61
price down icon 0.75%
$132.90
price up icon 1.21%
$313.13
price up icon 0.34%
Kapitalisierung:     |  Volumen (24h):